Antoine Jomier

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Karista SAS is an Independent Venture Capital firm founded in 2000. Cap Décisif Management SAS is headquartered in Paris, France.

CDC Enterprises, Inc. designs, manufactures, and distributes patented HDPE ductwork products. It offers airtight, mildew, corrosion resistant, and thermal constructed ductwork products. The firm specializes in electrical instrumentation, controls and systems integration, for public works, utilities, private industry, and government organizations. It provides a wide range of services including pump efficiency monitoring, system diagnostics and troubleshooting, GPS mapping, robotic controls, panel design, and fabrication. The company was founded by Jon W. Jungers in April 2001 and is headquartered in Ringwood, IL.

MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.

ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France.

In Situ Training SAS provides medical training services. It specializes in e-medicine, Medical Training, In Situ Training, Digital Health, e-health and Training inside the OR. The company was founded by Patxi Ospital and Julien Delpech in 2015 and is headquartered in Pessac, France.

TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France.

VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.

INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.

Doctoconsult SAS operates an online portal, which provides telemedecine services. It specializes in mental health. The company was founded by Grevent Fanny Jacq in 2016 and is headquartered in Fresnes, France.

Algaïa SA generates products and fermentation processes for the chemical and pharmaceutical industry. It products include carrageenan’s, alginates, plant bio stimulants and specialty seaweed extracts. The firm offers biomass valorization, biochemical analyses and bioactivity measurement services. The company was founded by Rudy Pandjaitan on July 30, 2004 and is headquartered in Paris, France.

Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France.

Axess Vision Technology SA designs, develops, produces and commercializes surgical equipment. It offers video endoscope and electro-therapeutic products. The company was founded by Olivier Brosset, Marc Malou, Olivier Fructus and Nicolas Mathieu in February 24, 2006 and is headquartered in Saint-Pierre-des-Corps, France.

Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France.

Prestodiag SAS develops, manufactures and markets a life science developments platform aimed at reducing the time and effort to detect microbiological pathogens. Its products include MonoPresto and Detection Kits. The company was founded by Thierry Livache, Thibaut Mercey and Felix Piat in March 2012 and is headquartered in Villejuif, France.

Watchfrog SA creates and markets solutions for the in vivo detection of chemical, pharmaceutical and cosmetic substances. The firm offers to incorporate in vivo significance to early in vitro stage of drug discovery. It also offers biotechnological tools to accelerate environmental risk assessment. The company was founded by Barbara Demeneix and Gregory Lemkine in 2005 and is headquartered in Evry, France.

Tricares SAS commercializes medical device. The company was founded by Coralie Marchand and Pascal Lim on September 2, 2013 and is headquartered in Paris, France.

Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

Innobio FCPI seeks investment opportunities in companies located in France. The fund focuses on innovative technology products and services in the healthcare market. It provides financing for early stage capital requirements and can invest between EUR 3 and EUR 10 million per target.